Drug intelligence / Profile preview

lactobacillus bulgaricus + streptococcus thermophilus + bifidobacterium lactis + lactobacillus acidophilus + lactobacillus plantarum ST-III + inulin

Development stage: Preclinical
Lead developer: LactoResearch
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

This product is a synbiotic, a combination of probiotic bacteria and a prebiotic fiber. It contains multiple strains of bacteria: *Lactobacillus bulgaricus*, *Streptococcus thermophilus*, *Bifidobacterium lactis*, *Lactobacillus acidophilus*, and a specific strain *Lactobacillus plantarum ST-III*. These live microorganisms are intended to colonize the gastrointestinal tract, supporting a healthy balance of gut microbiota. The inclusion of inulin, a type of prebiotic fiber, serves as a food source for these beneficial bacteria, promoting their growth and activity. This combination works synergistically to improve digestion, modulate the immune system, and form a protective barrier in the gut against pathogens. Probiotics like *Lactobacillus plantarum* are known to produce antimicrobial substances, help balance gut flora, and may offer anti-inflammatory and antioxidant benefits.

Beyond the preview

Go deeper on lactobacillus bulgaricus + streptococcus thermophilus + bifidobacterium lactis + lactobacillus acidophilus + lactobacillus plantarum ST-III + inulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactobacillus bulgaricus + streptococcus thermophilus + bifidobacterium lactis + lactobacillus acidophilus + lactobacillus plantarum ST-III + inulin.

Explore the full profile